홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Benzeneacetonitrile, 4-bromo- → 2-[4-[[8-(4-Fluorophenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]acetonitrile

HRID 452
인쇄

반응식

HRID 452 반응식
N#CCc1ccc(Br)cc1.Nc1nc2n(n1)CCC[C@@H]2c1ccc(F)cc1>C1COCCO1.O=C([O-])[O-].[Cs+].[Cs+].c1ccc(-c2ccccc2P(C2CCCCC2)C2CCCCC2)cc1>N#CCc1ccc(Nc2nc3n(n2)CCCC3c2ccc(F)cc2)cc1
참가 물질반응 조건실험 절차출처 및 근거반응 노트

참가 물질

6

반응물 2

HCID 27914Benzeneacetonitrile, 4-bromo-HCID 178418219HCID 178418219, 화합물

생성물 1

HCID 1187179422-[4-[[8-(4-Fluorophenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]acetonitrile수율 42.09%

시약·촉매·용매 3

HCID 10796Cesium carbonate시약HCID 27342162-(Dicyclohexylphosphino)biphenyl
촉매
HCID 312751,4-Dioxane용매

반응 조건

온도
120 °C

실험 절차

8-(4-fluorophenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-amine (98 mg, 0.42 mmol), 2-(4-bromophenyl)acetonitrile (83 mg, 0.42 mmol), Cesium carbonate (206 mg, 0.63 mmol), Palladium(II) acetate (9.47 mg, 0.04 mmol) and 2-(Dicyclohexylphosphino)biphenyl (14.79 mg, 0.04 mmol) were added to a 2-5 mL microwave vial. The vial was capped and flushed with nitrogen. dioxane (2 mL) was added and the vial was flushed with additional nitrogen before it was heated by microwave irradiation at 120°C for 1.5h. PALLADIUM(II) ACETATE (10 mg, 0.04 mmol) and 2-(DICYCLOHEXYLPHOSPHINO)BIPHENYL (14 mg, 0.04 mmol) were added and the mixture was heated for 45+30 min at 120° in a microwave reactor.Water (2 ml) and dichloromethane (10 ml) was added and the mixture was added to a phase separator tube. The organic phase was collected and evaporated. The solvents were evaporated and the residue was purified by column chromatography on silica eluting with gradients of methanol and ammonia in dichloromethane. The solvents were evaporated to give EN04671-48-001 (55 mg, 0.158 mmol, 37.5 %). Ca 88% pure according to LC-UV. The residue was dissolved in MeCN (2 ml) and the solution was passed through a syringe filter. Water was added to give a cloudy mixture (sample-002). Not possible to isolate solid by filtration. The solvents were evaporated to give EN04671-48-002. Not pure. EtOAc (2ml) and DCM (0.5 ml) and two drops of methanol were added. Most solid into solution. The mixture was passed through a syringe filter. The filter was rinsed with EtOAc (1 ml). Heptane was added until a solid started to form. The mixture was left for 1 h (sample -003). The mixture was filtered, everything passed through the filter. The solvents were evaporated and the residue was dissolved in MeCN and purified by preparative HPLC. Fr 1-2 were pooled and evaporated to give EN04671-48-004 (6.7 mg, 0.019 mmol, 4.57 %). Fr 3-6 were pooled and evaporated.

출처 및 근거

ORD 기록
ord-8b74efad6e6646bdaf4fdb6de38026cc
출처 데이터셋
750 AstraZeneca ELN dataset
원본 링크
출처 보기

반응 노트

이 페이지에서참가 물질반응 조건실험 절차출처 및 근거반응 노트